Clinical Trials Directory

Trials / Completed

CompletedNCT02129270

Hematoma Block for Reduction of Distal Radius Fractures

Phase 4 Study of Hematoma Block for Reduction of Distal Radius Fractures

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
24 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to Prove that injection of 15 to 20 mL of lidocaine 1% into the fracture site (Hematoma block) is more effective in terms of pain relieving then injection of 10 mL of lidocaine 2%, and equally safe in terms of complications, for closed reduction of distal radius fractures.

Conditions

Interventions

TypeNameDescription
DRUGLidocaine HCl 2% .comparison of different dosages of drug
DRUGLidocaine HCl 1%comparison of different dosages of drug

Timeline

Start date
2014-05-01
Primary completion
2015-02-01
Completion
2018-08-01
First posted
2014-05-02
Last updated
2020-02-17

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02129270. Inclusion in this directory is not an endorsement.